Agilus Diagnostics Appoints Vijender Singh as Managing Director & CEO

Lead

Agilus Diagnostics Limited, a subsidiary of Fortis Healthcare Limited, has appointed Vijender Singh as its Managing Director and Chief Executive Officer. The appointment became effective on July 20, 2026, marking a significant leadership transition for the diagnostics service provider.

What changed

Vijender Singh assumed the role of Managing Director and Chief Executive Officer at Agilus Diagnostics. This appointment follows the resignation of Dr. Anand K, who departed from the organisation after nearly six years to pursue other opportunities. Mr. Singh brings over three decades of leadership experience from the diagnostics, healthcare, consumer healthcare, and FMCG sectors. His previous leadership positions include Chairman and Managing Director of Diagnum Healthcare, Group CEO of Metropolis Healthcare, and CEO of Healthians, alongside a tenure at Dr. Lal PathLabs.

Why it matters

This leadership change introduces a seasoned executive to Agilus Diagnostics at a time when the diagnostics industry is experiencing transformation. Mr. Singh's extensive experience is noted for his track record in building and scaling businesses, driving operational excellence, strengthening governance frameworks, and fostering high-performing organisations. His deep understanding of the diagnostics sector, particularly from prior roles at major Indian diagnostics platforms, positions him to lead Agilus in its stated goals of enhancing customer experience and reinforcing its market position.

What to watch

With the appointment effective immediately, stakeholders will observe the strategic direction and operational priorities set by the new leadership at Agilus Diagnostics. Future disclosures from Fortis Healthcare or Agilus Diagnostics may provide further insights into the company's growth plans under Mr. Singh's leadership.

Source: Exchange filing.